These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14671865)

  • 1. Pharma focus. Market traders.
    Lewis C
    Health Serv J; 2003 Nov; 113(5883):suppl 2-3. PubMed ID: 14671865
    [No Abstract]   [Full Text] [Related]  

  • 2. New drug pricing scheme could politicise decisions and reduce access, says think tank.
    O'Dowd A
    BMJ; 2013 May; 346():f2965. PubMed ID: 23657194
    [No Abstract]   [Full Text] [Related]  

  • 3. Capping drug costs.
    Dean M
    Lancet; 1994 Jul; 344(8918):321. PubMed ID: 7914269
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
    Read P
    BMJ; 1998 Jan; 316(7126):226; author reply 228. PubMed ID: 9468700
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals. Plunder and pillage.
    Earl-Slater A
    Health Serv J; 1999 May; 109(5653):18-20. PubMed ID: 10387802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharma focus. Saints and sinners.
    Lewis C
    Health Serv J; 2003 Nov; 113(5883):suppl 5. PubMed ID: 14671866
    [No Abstract]   [Full Text] [Related]  

  • 7. Waiving the rules.
    Taylor D
    Health Serv J; 1992 Jun; 102(5305):20-2. PubMed ID: 10171042
    [No Abstract]   [Full Text] [Related]  

  • 8. Time to fix the price fix.
    Earl-Slater A
    Health Serv J; 1997 Nov; 107(5578):22-3. PubMed ID: 10174008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating the pharmaceutical industry.
    Maynard A; Bloor K
    BMJ; 1997 Jul; 315(7102):200-1. PubMed ID: 9253257
    [No Abstract]   [Full Text] [Related]  

  • 10. International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom.
    Gross DJ; Ratner J; Perez J; Glavin SL
    Health Care Financ Rev; 1994; 15(3):127-40. PubMed ID: 10137794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmaceutical price regulation scheme.
    Collier J
    BMJ; 2007 Mar; 334(7591):435-6. PubMed ID: 17332539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UK pharmaceutical market. An overview.
    Towse A
    Pharmacoeconomics; 1996; 10 Suppl 2():14-25. PubMed ID: 10163432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New NICE criteria for drug access.
    Fricker J
    Lancet Oncol; 2017 May; 18(5):576. PubMed ID: 28343973
    [No Abstract]   [Full Text] [Related]  

  • 14. The market for pharmaceuticals.
    Bergenheim K; Braun U
    Dev Health Econ Public Policy; 1998; 7():187-208. PubMed ID: 10538829
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating the pharmaceutical industry. Regulation may no longer be necessary.
    Rowlatt P
    BMJ; 1998 Jan; 316(7126):227; author reply 228. PubMed ID: 9468702
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes to the regulation of drug prices in the UK.
    Collier J
    BMJ; 2008 Dec; 337():a2735. PubMed ID: 19114449
    [No Abstract]   [Full Text] [Related]  

  • 17. NHS spending on drugs is frozen for two years under price deal.
    Wise J
    BMJ; 2013 Nov; 347():f6731. PubMed ID: 24201064
    [No Abstract]   [Full Text] [Related]  

  • 18. Pfizer to make palbociclib temporarily free on NHS.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e309. PubMed ID: 28506556
    [No Abstract]   [Full Text] [Related]  

  • 19. Nine drug company chiefs are charged with conspiracy to defraud NHS.
    Dyer O
    BMJ; 2006 Apr; 332(7546):872. PubMed ID: 16613948
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulating the price of the UK's drugs: second thoughts after the government's first report.
    Earl-Slater A
    BMJ; 1997 Feb; 314(7077):365-8. PubMed ID: 9040338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.